title: Vascular rejection episodes reduce success in renal graft outcome after therapy with BMA 031.
authors.affiliation: Department of Surgery, Klinikum Grosshadern, München, FRG.
authors.forename: G
authors.initials: G
authors.lastname: Hillebrand
authors.forename: U
authors.initials: U
authors.lastname: Dendorfer
authors.forename: H E
authors.initials: HE
authors.lastname: Feucht
authors.forename: C
authors.initials: C
authors.lastname: Brockmeyer
authors.forename: J M
authors.initials: JM
authors.lastname: Gokel
authors.forename: W D
authors.initials: WD
authors.lastname: Illner
authors.forename: D
authors.initials: D
authors.lastname: Abendroth
authors.forename: C
authors.initials: C
authors.lastname: Kasper
authors.forename: W
authors.initials: W
authors.lastname: Land
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001808:Blood Vessels / Q000276:immunology; D004730:Endothelium, Vascular / Q000276:immunology; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007518:Isoantibodies / Q000276:immunology; D016030:Kidney Transplantation / Q000276:immunology / Q000379:methods* / Q000473:pathology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*; D012307:Risk Factors; D016019:Survival Analysis
chemical_list: D000911:Antibodies, Monoclonal; D007518:Isoantibodies; D011948:Receptors, Antigen, T-Cell